Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Grimm

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Methods (San Diego, Calif.)|November 5, 2002
Production methods for gene transfer vectors based on adeno-associated virus serotypesDirk Grimm
Silence|October 28, 2011
The dose can make the poison: lessons learned from adverse in vivo toxicities caused by RNAi overexpressionDirk Grimm
Advanced Drug Delivery Reviews|May 12, 2009
Small silencing RNAs: state-of-the-artDirk Grimm
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 5, 2012
All for one, one for all: new combinatorial RNAi therapies combat hepatitis C virus evolutionDirk Grimm
Signal Transduction and Targeted Therapy|October 13, 2024
A breath of fresh air: targeted non-viral in vivo gene correction in the mammalian lungJixin Liu, Dirk Grimm
Plos Biology|July 17, 2024
When size matters: A novel compact Cas12a variant for in vivo genome editingFelix Bubeck, Dirk Grimm
Cytotherapy|August 23, 2022
Boosters for adeno-associated virus (AAV) vector (r)evolutionJoanna Szumska, Dirk Grimm
Frontiers in Immunology|November 15, 2021
Adeno-Associated Viruses (AAV) and Host Immunity - A Race Between the Hare and the HedgehogKleopatra Rapti, Dirk Grimm
Biotechnology Journal|January 10, 2018
Split Cas9, Not Hairs - Advancing the Therapeutic Index of CRISPR TechnologyCarolin Schmelas, Dirk Grimm
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2021
Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous virusesJulia Fakhiri, Dirk Grimm
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Methods (San Diego, Calif.)|November 5, 2002
Production methods for gene transfer vectors based on adeno-associated virus serotypesDirk Grimm
Silence|October 28, 2011
The dose can make the poison: lessons learned from adverse in vivo toxicities caused by RNAi overexpressionDirk Grimm
Advanced Drug Delivery Reviews|May 12, 2009
Small silencing RNAs: state-of-the-artDirk Grimm
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 5, 2012
All for one, one for all: new combinatorial RNAi therapies combat hepatitis C virus evolutionDirk Grimm
Signal Transduction and Targeted Therapy|October 13, 2024
A breath of fresh air: targeted non-viral in vivo gene correction in the mammalian lungJixin Liu, Dirk Grimm
Plos Biology|July 17, 2024
When size matters: A novel compact Cas12a variant for in vivo genome editingFelix Bubeck, Dirk Grimm
Cytotherapy|August 23, 2022
Boosters for adeno-associated virus (AAV) vector (r)evolutionJoanna Szumska, Dirk Grimm
Frontiers in Immunology|November 15, 2021
Adeno-Associated Viruses (AAV) and Host Immunity - A Race Between the Hare and the HedgehogKleopatra Rapti, Dirk Grimm
Biotechnology Journal|January 10, 2018
Split Cas9, Not Hairs - Advancing the Therapeutic Index of CRISPR TechnologyCarolin Schmelas, Dirk Grimm
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2021
Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous virusesJulia Fakhiri, Dirk Grimm
Pageof 16